Cargando…

The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels

BACKGROUND: Lipoprotein(a) [Lp(a)] elevation is an important risk factor for coronary artery disease (CAD). However, the correlation between Lp(a) elevations and the risk of recurrent cardiovascular events in patients with established cardiovascular disease is controversial. Some studies have shown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lijun, Zheng, Jiamin, Gao, Beibei, Jin, Xiangbo, He, Ying, Zhou, Liang, Huang, Jinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013030/ https://www.ncbi.nlm.nih.gov/pubmed/35428179 http://dx.doi.org/10.1186/s12872-022-02618-5

Ejemplares similares

Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
por: Zhu, Lijun, et al.
Publicado: (2022)

Correction: Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
por: Zhu, Lijun, et al.
Publicado: (2022)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021)

Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease
por: Packard, Chris J.
Publicado: (2022)

Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol
por: Gulayin, Pablo E., et al.
Publicado: (2022)

Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease
por: Hoursalas, Athanasios, et al.
Publicado: (2022)

A Novel Method for Estimating Low-Density Lipoprotein (LDL) Levels: Total Cholesterol and Non-High-Density Lipoprotein (HDL) Can Be Used to Predict Abnormal LDL Level in an Apparently Healthy Population
por: Zhang, Guo-Ming, et al.
Publicado: (2018)

Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease
por: Dai, Wen, et al.
Publicado: (2018)

Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events
por: Gu, Jun-Xu, et al.
Publicado: (2022)

Approaches to Visualising Endocytosis of LDL-Related Lipoproteins
por: Siddiqui, Halima, et al.
Publicado: (2022)

High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study
por: Omote, Kazunori, et al.
Publicado: (2022)

Lipoprotein(a) Concentrations Correlate With LDL-C in Children With Type 1 and 2 Diabetes
por: Foster, Christy, et al.
Publicado: (2021)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022)

Impact of epicardial adipose tissue volume on hemodynamically significant coronary artery disease in Chinese patients with known or suspected coronary artery disease
por: Jin, Xiangbo, et al.
Publicado: (2023)

Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma
por: Guo, Yi, et al.
Publicado: (2021)

A randomized trial and novel SPR technique identifies altered lipoprotein-LDL receptor binding as a mechanism underlying elevated LDL-cholesterol in APOE4s
por: Calabuig-Navarro, M. V., et al.
Publicado: (2017)

Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein
por: van den Berg, Eline H., et al.
Publicado: (2022)

Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study
por: Xu, Na, et al.
Publicado: (2022)

Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease
por: van Buuren, Frank, et al.
Publicado: (2017)

Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD
por: Knowles, Joshua W, et al.
Publicado: (2008)

Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)

Elevated lipoprotein(a) levels as an independent predictor of long-term recurrent events in patients with acute coronary syndrome: an observational, retrospective cohort study
por: Yang, Si-qi, et al.
Publicado: (2022)

LDL retention time in plasma can be -based on causation- estimated by the lipid composition of LDL and other lipoproteins
por: Jansen, Martin, et al.
Publicado: (2022)

Reduced Right Frontal Fractional Anisotropy Correlated with Early Elevated Plasma LDL Levels in Obese Young Adults
por: Lou, Baohui, et al.
Publicado: (2014)

Case report: lipoprotein apheresis reduces the risk of cardiovascular events and prolongs pregnancy in a woman with severely elevated lipoprotein(a), cardiovascular disease, and a high risk of preeclampsia
por: Marlȩga-Linert, Joanna, et al.
Publicado: (2023)

Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation
por: Zhu, Zhongsheng, et al.
Publicado: (2019)

Elevated Homocysteine Intensify the Effect of Lipoprotein(a) on Stroke Recurrence
por: Feng, Zhiyuan, et al.
Publicado: (2022)

Mathematical Model for Low Density Lipoprotein (LDL) Endocytosis by Hepatocytes
por: Wattis, J. A. D., et al.
Publicado: (2008)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL
por: Li, Chuang, et al.
Publicado: (2021)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
por: Langslet, Gisle, et al.
Publicado: (2020)

α-Adducin gene G614T polymorphisms in essential hypertension patients with high low density lipoprotein (LDL) levels
por: Wang, Lifang, et al.
Publicado: (2014)

Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events
por: Cai, Hong-Bin, et al.
Publicado: (2019)

Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins
por: Leatherman, Sarah, et al.
Publicado: (2022)

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
por: Hirano, Tsutomu, et al.
Publicado: (2022)

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA
por: Kitagawa, Kazuo, et al.
Publicado: (2019)

The Contribution of Inflammation to Stroke Recurrence Attenuates at Low LDL-C Levels
por: Zhang, Xing, et al.
Publicado: (2022)

Elevated lipoprotein(a) as a predictor for coronary events in older men
por: Bartoli-Leonard, Francesca, et al.
Publicado: (2022)

Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences
por: Kathariya, Gobardhan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2i4iuvcrdtmactaguahjt2isdo